Larvol Delta - The-preclinical-efficacy-of-the-novel-hypomethylating-agent-NTX301-as-a-monotherapy-and-in-combination-with-venetoclax-in-acute-myeloid-leukemia

Venclexta (venetoclax) - Roche, AbbVie

NTX-301 - PinotBio, Aston Sci.

http://www.ncbi.nlm.nih.gov/pubmed/35410412

Apr 13, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next